Diagnostic test maker Meridian Bioscience‘s (NYSE:VIVO) Chief Executive Jack Kraeutler received a 3 percent increase in compensation this year to $843,000.
Here’s how Kraeutler’s 2011 compensation breaks down, according to a recent regulatory filing: $546,000 in base salary; $228,000 in stock awards and $69,000 in “other” compensation, which includes retirement contributions, auto allowance and financial planning.
Unlike most CEOs, Kraeutler was not his organization’s highest-paid employee. That distinction went to William Motto, the company’s executive chairman, who was paid $885,000 in 2011. Motto is Meridian’s founder and has been chairman of the company’s board since 1977, according to the regulatory document.
Beyond Analytics: How Sellers Dorsey is Hard-Coding Value into Medicaid Policy [Video]
How to turn analytics into actual policy outcomes.
For its fiscal year ended in September 2011, Meridian reported a 12 percent increase in sales to $160 million, and a 1 percent increase in profits to $27 million.
Earlier this week, Meridian announced that it had received U.S. regulatory approval to begin selling a new Clostridium difficile test.